Supervisors
All of our supervisors have a wealth of experience in running successful scientific projects resulting in high impact publications, patents and spin-out technologies and therapies, as well as the training of numerous PhD and MSc students. Our ESRs will benefit from this world-class supervision as this will make them attractive employees for the pharmaceutical, regulatory and a myriad of related healthcare-related industries.
|
Dr. Theodora Calogeropoulou, National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology
Supervisor ESR1 & ESR2 Expertise in: Medicinal chemistry and development of synthetic methodologies |
|
Prof. Rebecca Wade, HITS gGmbH, Molecular and Cellular Modeling Group
Supervisor ESR3 & ESR4 Expertise in: Computational Structural Biology |
|
Prof. Stefano Mangani, Universitita' degli Studi di Siena, Department of Biotechnology, Chemistry and Pharmacy
Supervisor ESR5 Expertise in: Chemistry |
|
Prof. Christophe Rochais, Université de Caen Normandie, UFR des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le médicament de Normandie, CERMN
Supervisor ESR6 Expertise in: Organic and Medicinal Chemistry |
|
Prof. Vassilios Roussis, National and Kapodistrian University of Athens, School of Pharmacy, Dept. of Pharmacognosy & Chemistry of Natural Products
Supervisor ESR7 Expertise in: Isolation and structural identification of secondary metabolites with pharmacological activity from marine macro- and microorganisms |
|
Dr. Vasileia-Ismini Alexaki, Technische Universität Dresden, Faculty of Medicine, Department of Clinical Pathobiochemistry
Supervisor ESR8 Expertise in: Molecular endocrinology |
|
Dr. Marie-Ann Ewart, AvantiCell Science Ltd.
Supervisor ESR9 & ESR10 Expertise in: Mammalian cell isolation, culture and analysis |
|
Prof. Achilleas Gravanis, Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology
Supervisor ESR11 & ESR12, WP2 Leader Expertise in: Brain hormonal microenvironment and neurotrophins during development and aging, of the molecular mechanisms involved in neurodegeneration & neurogenesis and development of synthetic small molecules with neuroprotective & neurogenic properties. |
|
Ass. Prof. Ka Wan Li, Stichting VU, Department of Molecular and Cellular Neurobiology
Supervisor ESR13 Expertise in: Neuroscience research |
|
Prof. Dame Pamela Shaw, University of Sheffield, Sheffield Institute for Translational Neuroscience
Supervisor ESR14 Expertise in: Translational Neuroscience and the Biomedical Research |
